Donghua Medical Technology Co., Ltd. announced that it will receive CNY 80 million in an equity round of funding on April 29, 2019. The transaction will include participation from returning investor DHC Software Co.,Ltd (SZSE:002065) which will continue to own 100% stake. Post the closing of the transaction, the registered capital of the company will be CNY 130 million. The transaction has been approved by the 26th meeting of the 6th directorate of the investor. The authority for examination and approval of this investment is within the external investment authority of the board of directors and does not need to be approved to the shareholders' meeting of investor. Han Shibin is the legal representative of the company.